Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clever Leaves Holdings Equity Warrant CLVRW

Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and... see more

Recent & Breaking News (GREY:CLVRW)

Clever Leaves Announces Voluntary Delisting and SEC Deregistration

GlobeNewswire April 26, 2024

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire April 1, 2024

Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia

GlobeNewswire February 13, 2024

Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)

GlobeNewswire January 3, 2024

Clever Leaves Reports Third Quarter 2023 Results

GlobeNewswire November 9, 2023

Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET

GlobeNewswire November 2, 2023

Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire September 13, 2023

Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company

GlobeNewswire August 29, 2023

Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements

GlobeNewswire August 24, 2023

Clever Leaves Reports Second Quarter 2023 Results

GlobeNewswire August 14, 2023

Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET

GlobeNewswire August 7, 2023

Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group

GlobeNewswire July 26, 2023

Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International Subsidiary

GlobeNewswire July 5, 2023

Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland

GlobeNewswire May 30, 2023

Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023

GlobeNewswire May 26, 2023

Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal

GlobeNewswire May 25, 2023

Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA

GlobeNewswire May 16, 2023

Clever Leaves to Present at Canaccord Genuity's 7th Annual Global Cannabis Conference

GlobeNewswire May 15, 2023

Clever Leaves Reports First Quarter 2023 Results

GlobeNewswire May 11, 2023

Clever Leaves to Hold First Quarter 2023 Conference Call on Thursday, May 11, 2023 at 5:00 p.m. ET

GlobeNewswire May 4, 2023